Massage therapy for children, adolescents, and young adults: Clinical delivery and effectiveness in hematology and oncology.
adolescents
children
massage therapy
oncology
sickle cell disease
symptom management
Journal
Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
revised:
17
01
2023
received:
28
10
2022
accepted:
18
01
2023
pubmed:
3
2
2023
medline:
25
2
2023
entrez:
2
2
2023
Statut:
ppublish
Résumé
Children, adolescents, and young adults with hematologic and/or oncologic conditions experience multiple, significant symptoms (e.g., pain, stress, and anxiety), which may be addressed by nonpharmacologic approaches such as massage therapy (MT). The purpose of this study was to describe the clinical delivery of MT provided by a certified pediatric massage therapist and assess effectiveness in two patient groups: those with sickle cell disease (SCD) or hematologic and/or oncologic conditions excluding SCD (HemOnc). Investigators conducted a retrospective review of MT sessions provided to patients 0-39 years with hematologic and/or oncologic conditions at a large pediatric academic medical center. Between October 2019 and December 2021, 3015 MT sessions were provided to 243 patients (171 HemOnc; 72 SCD) and documented in the electronic health record. Patients (mean age: 12.21 ± 7.19 years) were generally White (49.4%) or Black/African American (43.2%), non-Hispanic (94.2%), and 52.3% female. Patients in the SCD group (vs. patients in the HemOnc group) reported significantly higher (p < .05) pretreatment pain (6.95 vs. 4.46), stress (6.47 vs. 4.58), and anxiety (6.67 vs. 4.59). All patients reported clinically and statistically significant (p < .001) mean reductions in pain (-2.25 ± 1.87), stress (-2.50 ± 1.73), and anxiety (-2.52 ± 1.69), with patients in the HemOnc group reporting greater mean pain change (-2.54 vs. -1.87) than patients in the SCD group. This study supports the clinical effectiveness of MT for addressing acute pain, stress, and anxiety among youth with hematologic and/or oncologic conditions. Future research is needed to identify optimal MT utilization.
Sections du résumé
BACKGROUND
Children, adolescents, and young adults with hematologic and/or oncologic conditions experience multiple, significant symptoms (e.g., pain, stress, and anxiety), which may be addressed by nonpharmacologic approaches such as massage therapy (MT). The purpose of this study was to describe the clinical delivery of MT provided by a certified pediatric massage therapist and assess effectiveness in two patient groups: those with sickle cell disease (SCD) or hematologic and/or oncologic conditions excluding SCD (HemOnc).
METHODS
Investigators conducted a retrospective review of MT sessions provided to patients 0-39 years with hematologic and/or oncologic conditions at a large pediatric academic medical center.
RESULTS
Between October 2019 and December 2021, 3015 MT sessions were provided to 243 patients (171 HemOnc; 72 SCD) and documented in the electronic health record. Patients (mean age: 12.21 ± 7.19 years) were generally White (49.4%) or Black/African American (43.2%), non-Hispanic (94.2%), and 52.3% female. Patients in the SCD group (vs. patients in the HemOnc group) reported significantly higher (p < .05) pretreatment pain (6.95 vs. 4.46), stress (6.47 vs. 4.58), and anxiety (6.67 vs. 4.59). All patients reported clinically and statistically significant (p < .001) mean reductions in pain (-2.25 ± 1.87), stress (-2.50 ± 1.73), and anxiety (-2.52 ± 1.69), with patients in the HemOnc group reporting greater mean pain change (-2.54 vs. -1.87) than patients in the SCD group.
CONCLUSIONS
This study supports the clinical effectiveness of MT for addressing acute pain, stress, and anxiety among youth with hematologic and/or oncologic conditions. Future research is needed to identify optimal MT utilization.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e30243Informations de copyright
© 2023 The Authors. Pediatric Blood & Cancer published by Wiley Periodicals LLC.
Références
Jacobs S, Mowbray C. The power of massage in children with cancer-how can we do effective research? Children. 2019;6(1):13. doi:10.3390/children6010013
Steele AC, Mullins LL, Mullins AJ, Muriel AC. Psychosocial interventions and therapeutic support as a standard of care in pediatric oncology. Pediatr Blood Cancer. 2015;62:S585-S618. doi:10.1002/pbc.25701
Uwaezuoke SN, Ayuk AC, Ndu IK, Eneh CI, Mbanefo NR, Ezenwosu OU. Vaso-occlusive crisis in sickle cell disease: current paradigm on pain management. J Pain Res. 2018;11:3141-3150. doi:10.2147/JPR.S185582
Yun H, Romero SAD, Record B, et al. Utilization of integrative medicine differs by age among pediatric oncology patients. Pediatr Blood Cancer. 2019;66(6):e27639. doi:10.1002/pbc.27639
Fuller C, Huang H, Thienprayoon R. Managing pain and discomfort in children with cancer. Curr Oncol Rep. 2022;24(8):961-973. doi:10.1007/s11912-022-01277−1
Desai K, Liou K, Liang K, Seluzicki C, Mao JJ. Availability of integrative medicine therapies at National Cancer Institute-designated comprehensive cancer centers and community hospitals. J Altern Complement Med. 2021;27(11):1011-1013. doi:10.1089/acm.2021.0102
Rodríguez-Mansilla J, González-Sánchez B, Torres-Piles S, Guerrero Martín J, Jiménez-Palomares M, Bellino M. Effects of the application of therapeutic massage in children with cancer: a systematic review. Rev Lat Am Enfermagem. 2017;25:e2903. doi:10.1590/1518-8345.1774.2903
Batalha LMDC, Mota AASC. Massage in children with cancer: effectiveness of a protocol. J Pediatr (Rio J). 2013;89(6):595-600. doi:10.1016/j.jped.2013.03.022
Mao JJ, Ismaila N, Bao T, et al. Integrative medicine for pain management in oncology: Society for Integrative Oncology-ASCO guideline. J Clin Oncol. 2022;40(34):3998-4024. doi:10.1200/JCO.22.01357
Andemariam B, Jones S. Development of a new adult sickle cell disease center within an academic cancer center: impact on hospital utilization patterns and care quality. J Racial Ethn Health Disparities. 2016;3(1):176-182. doi:10.1007/s40615-015-0142-7
Ahmadi M, Ilkhani M, Beiranvand S, Poormansouri S, Sedighie L. Massage for pain management in patients with sickle cell disease: a review study. Jundishapur J Chronic Dis Care. 2017;7(1):e62315. doi:10.5812/jjcdc.62315
Ezenwa MO, Molokie RE, Wang ZJ, et al. Differences in sensory pain, expectation, and satisfaction reported by outpatients with cancer or sickle cell disease. Pain Manag Nurs. 2018;19(4):322-332. doi:10.1016/j.pmn.2017.11.010
Darbari DS, Sheehan VA, Ballas SK. The vaso-occlusive pain crisis in sickle cell disease: definition, pathophysiology, and management. Eur J Haematol. 2020;105(3):237-246. doi:10.1111/ejh.13430
Schatz AA, Oliver TK, Swarm RA, et al. Bridging the gap among clinical practice guidelines for pain management in cancer and sickle cell disease. J Natl Compr Canc Netw. 2020;18(4):392-399. doi:10.6004/jnccn.2019.7379
Power-Hays A, McGann PT. When actions speak louder than words - racism and sickle cell disease. N Engl J Med. 2020;383(20):1902-1903. doi:10.1056/NEJMp2022125
Ackerman SL, Lown EA, Dvorak CC, et al. Massage for children undergoing hematopoietic cell transplantation: a qualitative report. Evid Based Complement Alternat Med. 2012;2012:792042. doi:10.1155/2012/792042
Phipps S, Peasant C, Barrera M, Alderfer MA, Huang Q, Vannatta K. Resilience in children undergoing stem cell transplantation: results of a complementary intervention trial. Pediatrics. 2012;129(3):e762-e770. doi:10.1542/peds.2011-1816
Post-White J, Fitzgerald M, Savik K, Hooke MC, Hannahan AB, Sencer SF. Massage therapy for children with cancer. J Pediatr Oncol Nurs. 2009;26(1):16-28. doi:10.1177/1043454208323295
Coccia PF, Pappo AS, Altman J, et al. Adolescent and young adult oncology, version 2.2014. J Natl Compr Canc Netw. 2014;12(1):21-32. doi:10.6004/jnccn.2014.0004
Walton T. Medical Conditions and Massage Therapy. Jones & Bartlett Learning; 2020.
Lopez G, Lacey J, Christie AJ, et al. Patient-reported outcomes in integrative oncology: bridging clinical care with research. Cancer J. 2019;25(5):311-315. doi:10.1097/PPO.0000000000000401
IBM SPSS Statistics for macOS. IBM; 2021.
Kazak AE, Abrams AN, Banks J, et al. Psychosocial assessment as a standard of care in pediatric cancer. Pediatr Blood Cancer. 2015;62:S426-S459. doi:10.1002/pbc.25730
Wiener L, Kazak AE, Noll RB, Patenaude AF, Kupst MJ. Standards for the psychosocial care of children with cancer and their families: an introduction to the special issue. Pediatr Blood Cancer. 2015;62:S419-S424. doi:10.1002/pbc.25675
Mehling WE, Lown EA, Dvorak CC, et al. Hematopoietic cell transplant and use of massage for improved symptom management: results from a pilot randomized control trial. Evid Based Complement Alternat Med. 2012;2012:450150. doi:10.1155/2012/450150
Phipps S, Barrera M, Vannatta K, Xiong X, Doyle JJ, Alderfer MA. Complementary therapies for children undergoing stem cell transplantation: report of a multisite trial. Cancer. 2010;116(16):3924-3933. doi:10.1002/cncr.25415
Genik LM, McMurtry CM, Marshall S, Rapoport A, Stinson J. Massage therapy for symptom reduction and improved quality of life in children with cancer in palliative care: a pilot study. Complement Ther Med. 2020;48:102263. doi:10.1016/j.ctim.2019.102263
Twycross A, Parker R, Williams A, Gibson F. Cancer-related pain and pain management: sources, prevalence, and the experiences of children and parents. J Pediatr Oncol Nurs. 2015;32(6):369-384. doi:10.1177/1043454214563751
Ballas SK, Gupta K, Adams-Graves P. Sickle cell pain: a critical reappraisal. Blood. 2012;120(18):3647-3656. doi:10.1182/BLOOD-2012-04-383430
Schneider MB, Manikowski A, Cohen L, Dampier C, Sil S. The distinct longitudinal impact of pain catastrophizing on pain interference among youth living with sickle cell disease and chronic pain. J Behav Med. 2022;45(4):622-631. doi:10.1007/s10865-021-00280-4
Fearon A, Marsh A, Kim J, Treadwell M. Pediatric residents’ perceived barriers to opioid use in sickle cell disease pain management. Pediatr Blood Cancer. 2019;66(2):e27535. doi:10.1002/pbc.27535
Myrvik MP, Brandow AM, Drendel AL, Yan K, Hoffmann RG, Panepinto JA. Clinically meaningful measurement of pain in children with sickle cell disease. Pediatr Blood Cancer. 2013;60(10):1689-1695. doi:10.1002/pbc.24624
Zempsky WT, Palermo TM, Corsi JM, Lewandowski AS, Zhou C, Casella JF. Daily changes in pain, mood and physical function in youth hospitalized for sickle cell disease pain. Pain Res Manag. 2013;18(1):33-38. doi:10.1155/2013/487060
Reece-Stremtan S, Mahmood L, Margulies S, et al. Acupuncture as an adjunctive treatment for pain in hospitalized children with sickle cell disease. J Pain Symptom Manage. 2021;62(6):1239-1244. doi:10.1016/j.jpainsymman.2021.06.003
Pain assessment and management - understanding the requirements. The Joint Commission; 2022. Accessed July 1, 2022. https://www.jointcommission.org/standards/standard-faqs/hospital-and-hospital-clinics/leadership-ld/000002161/
Tick H, Nielsen A, Pelletier KR, et al. Evidence-based nonpharmacologic strategies for comprehensive pain care: the consortium pain task force white paper. Explore. 2018;14(3):177-211. doi:10.1016/j.explore.2018.02.001
Chokshi SK, Ladas EJ, Taromina K, et al. Predictors of acupuncture use among children and adolescents with cancer. Pediatr Blood Cancer. 2017;64(7):e26424. doi:10.1002/pbc.26424
Mikhail A, Reidy JF, Taylor PR, Scoble JE. Renal artery embolization after back massage in a patient with aortic occlusion. Nephrol Dial Transplant. 1997;12(4):797-798. doi:10.1093/ndt/12.4.797
Trotter JF. Hepatic hematoma after deep tissue massage. N Engl J Med. 1999;341(26):2019-2020. doi:10.1056/NEJM199912233412616
Corbin L. Safety and efficacy of massage therapy for patients with cancer. Cancer Control. 2005;12(3):158-164. doi:10.1177/107327480501200303
Jane SW, Chen SL, Wilkie DJ, et al. Effects of massage on pain, mood status, relaxation, and sleep in Taiwanese patients with metastatic bone pain: a randomized clinical trial. Pain. 2011;152(10):2432-2442. doi:10.1016/j.pain.2011.06.021